Table 2.
Organ | Treatment | Protein (μg/mg tissue) | TBARS (nM/min/ mg tissue) | CAT (U/min) | SOD (U/mg protein) | GSH (mM/g tissue) |
---|---|---|---|---|---|---|
Cortex | NC | 0.97 ± 0.09 | 9.09 ± 0.9 | 4.4 ± 0.11 | 1.2 ± 0.01 | 6.2 ± 0.36 |
PC | 0.65 ± 0.08NS | 14.5 ± 2.1NS | 3.7 ± 0.06*** | 1.02 ± 0.01** | 4.9 ± 0.25NS | |
AC | 0.56 ± 0.14* | 22 ± 2.9*** | 2.5 ± 0.09*** | 0.5 ± 0.06*** | 1.6 ± 0.18*** | |
AC + HNC | 1.06 ± 0.11NS | 7.94 ± 1.4NS | 4.3 ± 0.08NS | 1.6 ± 0.01*** | 6.3 ± 0.61NS | |
AC + lupeol | 1.04 ± 0.19NS | 6.44 ± 1.21NS | 3.1 ± 0.08*** | 1.9 ± 0.01*** | 7.6 ± 0.48NS | |
Cerebellum | NC | 0.77 ± 0.07 | 12.7 ± 1.5 | 5.0 ± 0.05 | 1.1 ± 0.01 | 4 ± 0.53 |
PC | 0.83 ± 0.09NS | 11.0 ± 1.5NS | 4.2 ± 0.03*** | 0.7 ± 0.16** | 3.7 ± 0.34NS | |
AC | 0.38 ± 0.07* | 27.7 ± 2.4*** | 3.2 ± 0.03*** | 0.3 ± 0.02*** | 2.8 ± 0.22NS | |
AC + HNC | 0.93 ± 0.09NS | 12.8 ± 1.51NS | 4.8 ± 0.09* | 1.2 ± 0.003NS | 4.01 ± 0.45NS | |
AC + lupeol | 0.88 ± 0.13NS | 7.71 ± 1.3NS | 3.9 ± 0.03*** | 1.3 ± 0.02NS | 3.07 ± 0.28NS | |
Liver | NC | 5.41 ± 0.40 | 10.0 ± 1.2 | 12.3 ± 0.33 | 4.2 ± 0.01 | 14.7 ± 0.41 |
PC | 5.43 ± 0.28NS | 8.44 ± 2.14NS | 13.0 ± 0.15NS | 3.03 ± 0.01*** | 12.0 ± 0.60NS | |
AC | 3.27 ± 0.12** | 12.8 ± 1.9*** | 9.8 ± 0.08*** | 1.3 ± 0.09*** | 8.8 ± 0.76*** | |
AC + HNC | 6.34 ± 0.6NS | 8.76 ± 2.0NS | 14.1 ± 0.17*** | 3.9 ± 0.09* | 15.5 ± 0.64NS | |
AC + lupeol | 5.85 ± 0.62NS | 6.58 ± 1.6NS | 11.5 ± 0.4NS | 4.5 ± 0.11* | 16.8 ± 1.12NS |
Where “NC” is normal control, “PC” is positive control (Rivastigmine), “AC” is Alzheimer control and “HNC” is H. nepalensis crude extract. Values are *p < 0.05, **p < 0.01 and *** p < 0.01 statistically significant as compared to AC group expressed as means ± SEM whereas NS represents non-significant